v3.26.1
Note 10 - Share Capital (Details Textual) - USD ($)
 12 Months Ended
May 09, 2024
Mar. 07, 2024
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Common Stock, Shares Authorized (in shares)     1,500,000,000 1,500,000,000  
Preferred Stock, Shares Authorized (in shares)     50,000,000 50,000,000  
Proceeds from Issuance of Common Stock     $ 0 $ 9,862,207  
Stock Issued During Period, Shares, New Issues (in shares)     0 18,750,000  
Common Stock, No Par Value (in dollars per share)   $ 0 $ 0 $ 0  
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)     $ 0.77 $ 0.77 $ 0
VidaCann, LLC [Member]          
Stock Issued During Period, Shares, Acquisitions (in shares) 80,564,554   0 80,564,554  
VidaCann, LLC [Member] | VC Advisor [Member]          
Stock Issued During Period, Shares, Acquisitions (in shares) 1,307,698   0 1,307,698  
Public Offering [Member]          
Proceeds from Issuance of Common Stock   $ 11,300,000      
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)   1      
Warrants and Rights Outstanding, Term (Year)   5 years      
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)   $ 0.77      
Public Offering [Member]          
Stock Issued During Period, Shares, New Issues (in shares)   18,750,000      
Shares Issued, Price Per Share (in dollars per share)   $ 0.6      
Number of Shares Per Unit Issued (in shares)   1      
Common Stock, No Par Value (in dollars per share)   $ 0      
Number of Warrants Per Unit (in shares)   1      
Restricted Stock Units (RSUs) [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)     23,930,635 485,185  
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period (in shares)     507,000 185,185  
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period (in shares)     1,780,931 0  
Proceeds from Issuance of Common Stock     $ 0 $ 0  
Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation (in shares)     (0) 83,333  
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Settled in Period (in shares)       1,224,278